Essen Instruments Inc dba Essen Bioscience
- View government funding actions
- Ann Arbor, MI 481089624
- Phone: 734-769-1600
- Corporate URL: www.essenbio.com
- Estimated Number of Employees: 45
- Estimated Annual Receipts: $4,500,000
- Business Start Date: 1999
- Contact Person: Ashley Moseby
- Contact Phone: 734-474-1790
- Contact Email: ashley.moseby@essenbio.com
- Business Structure:
- Corporate Entity (Tax Exempt)
- Business Type:
- For Profit Organization
- Industries Served: Analytical Laboratory Instrument Manufacturing, Research and Development in Biotechnology
- Product Areas: FIRE FIGHTING EQUIPMENT, Haz. Mat. Spill Cntnmnt. & Clean-up, HAZARDOUS MATERIAL SPILL CONTAINMENT AND CLEAN-UP EQUIPMENT AND MATERIAL, SAFETY AND RESCUE EQUIPMENT, PREFABRICATED AND PORTABLE BUILDINGS, PREFABRICATED & PORTABLE BUILDINGS, RIGID WALL SHELTERS, MISC PREFABRICATED STRUCTURES, MISCELLANEOUS PREFABRICATED STRUCTURES, TENTS AND TARPAULINS, MOD OF TEXTILES-LEATHER-FURS, MODIFICATION OF EQUIPMENT- TEXTILES, LEATHER, FURS, APPAREL AND SHOE FINDINGS, TENTS AND FLAGS, INSTALLATION OF EQUIPMENT- PREFABRICATED STRUCTURES AND SCAFFOLDING, INSTALL OF PREFAB STRUCTURES, INSTALL OF TEXTILES-LEATHER-FURS, INSTALLATION OF EQUIPMENT- TEXTILES, LEATHER, FURS, APPAREL AND SHOE FINDINGS, TENTS AND FLAGS
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $36,436 - Wednesday the 12th of September 2012
Department Of Army
W4PZ USA MED RSCH ACQUIS ACT
HERG INHIBITION ASSAY 8 POINT, - $30,000 - Friday the 31st of August 2012
National Institutes Of Health
NIH, NIDA, OD OM OA OFC ACQUISITIONS
NIH DRUG DEVELOPMENT CONSULTING SERVICES - $3,000 - Monday the 7th of November 2011
National Institutes Of Health
NIH, NIDA, OD OM OA OFC ACQUISITIONS
NIH DRUG DEVELOPMENT CONSULTING SERVICES - $20,850 - Wednesday the 19th of September 2012
Department Of Army
W4PZ USA MED RSCH ACQUIS ACT
HERG INHIBITION ASSAY 1 POINT PERCENT
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.